Attività
Numero di dipendenti: 46
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
David Gaiero
DFI | Director of Finance/CFO | 45 | 01/12/20 |
Susan Doleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/19 |
Judson Englert
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/20 |
General Counsel | - | 03/05/22 | |
Gale Cohen
HRO | Human Resources Officer | - | 01/05/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
John Thero
BRD | Director/Board Member | 63 | 04/02/22 |
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
Jean George
BRD | Director/Board Member | 66 | 01/04/13 |
Chairman | 60 | 01/01/18 | |
Stephen Sands
BRD | Director/Board Member | 67 | 22/02/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 36 005 401 | 33 493 836 ( 93,02 %) | 7 333 ( 0,0204 %) | 93,02 % |
Coordinate società
![Indirizzo Cyteir Therapeutics, Inc.(CYTT)](https://cdn.zonebourse.com/static/address/123863828.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,97% | 45,34 Mrd | |
+41,98% | 40,42 Mrd | |
-10,06% | 37,92 Mrd | |
+31,15% | 31,75 Mrd | |
-7,79% | 27,71 Mrd | |
+13,32% | 26,52 Mrd | |
+43,05% | 13,96 Mrd | |
+31,28% | 12,44 Mrd | |
-7,41% | 11,26 Mrd |